Adverum Biotechnologies, Inc. Insider Trading for February 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adverum Biotechnologies, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Adverum Biotechnologies, Inc. for February 2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 13 2017 | AAVL | Adverum Biotechnol ... | Salzman Amber | President and CEO | Option Exercise | A | 2.70 | 378,000 | 1,020,600 | 378,000 | |
Feb 13 2017 | AAVL | Adverum Biotechnol ... | Salzman Amber | President and CEO | Grant | A | 0.00 | 262,000 | 0 | 891,766 | 629.8 K to 891.8 K (+41.60 %) |
Feb 13 2017 | AAVL | Adverum Biotechnol ... | PATTERSON LEONE D | CFO | Option Exercise | A | 2.70 | 116,000 | 313,200 | 116,000 | |
Feb 13 2017 | AAVL | Adverum Biotechnol ... | PATTERSON LEONE D | CFO | Grant | A | 0.00 | 80,000 | 0 | 180,000 | 100 K to 180 K (+80.00 %) |
Feb 13 2017 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | Chief Science & Tec ... | Option Exercise | A | 2.70 | 181,000 | 488,700 | 181,000 | |
Feb 13 2017 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | Chief Science & Tec ... | Grant | A | 0.00 | 125,000 | 0 | 289,535 | 164.5 K to 289.5 K (+75.97 %) |
Feb 13 2017 | AAVL | Adverum Biotechnol ... | Barone Samuel B. | SVP, Clinical Devel ... | Option Exercise | A | 2.70 | 84,000 | 226,800 | 84,000 | |
Feb 13 2017 | AAVL | Adverum Biotechnol ... | Barone Samuel B. | SVP, Clinical Devel ... | Grant | A | 0.00 | 58,000 | 0 | 172,335 | 114.3 K to 172.3 K (+50.73 %) |
Feb 02 2017 | AAVL | Adverum Biotechnol ... | Woiwode Thomas | Director | Grant | A | 0.00 | 3,449 | 0 | 37,952 | 34.5 K to 38 K (+10.00 %) |